Literature DB >> 17899145

Parotid localized Castleman's disease and HHV-8 infection: a case report.

Elisabetta Caselli1, Davide Padovani, Roberto Di Carlo, Enrico Grandi, Monica Galvan, Enzo Cassai, Antonio Pastore.   

Abstract

Castleman's disease (CD) is an unusual massive proliferation of lymphoid tissue distinct in two clinical forms, localized and multicentric. The multicentric form has been related to human herpesvirus 8 (HHV-8), especially in HIV-infected patients, whereas the localized form of CD is still unrelated to viral pathogens. We report a case of a HIV-negative 16-year-old male referred to our hospital with a 12-month history of a painless swelling in his right parotid region. A parotidectomy was performed, and histological analysis evidenced a localized CD. The search for HHV-8 revealed an active virus infection. The patient was commenced on corticosteroid therapy and a follow-up was performed every 6 months. The patient was commenced on corticosteroid therapy and there has been no recurrence after 24 months. The authors report a case of localized parotid CD in a patient with evidence of an active HHV-8 infection. The results of this study does for the first time suggest an association between HHV-8 and localized CD in HIV-negative subjects.

Entities:  

Mesh:

Year:  2007        PMID: 17899145     DOI: 10.1007/s00405-007-0453-3

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  21 in total

1.  Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group.

Authors:  D F Martin; B D Kuppermann; R A Wolitz; A G Palestine; H Li; C A Robinson
Journal:  N Engl J Med       Date:  1999-04-08       Impact factor: 91.245

2.  Role of cytomegalovirus, Epstein-Barr virus, and human herpes virus-8 in benign lymphoepithelial cysts of the parotid gland.

Authors:  Thomas L Yen; Andrew H Murr; Joseph Rabin; Anand N Mhatre; Anil K Lalwani
Journal:  Laryngoscope       Date:  2004-08       Impact factor: 3.325

3.  Parotid presentation of Castleman's disease: report of a case.

Authors:  D W Goodisson; R J Carr; R W Stirling
Journal:  J Oral Maxillofac Surg       Date:  1997-05       Impact factor: 1.895

4.  Prevalence and distribution of HHV-8 in different subpopulations, with and without HIV infection, in Spain.

Authors:  G Gambús; D Bourboulia; A Esteve; R Lahoz; C Rodriguez; F Bolao; G Sirera; R Muga; J del Romero; C Boshoff; D Whitby; J Casabona
Journal:  AIDS       Date:  2001-06-15       Impact factor: 4.177

5.  Castleman disease (giant lymph node hyperplasia) in the maxillofacial region: a report of 3 cases.

Authors:  A Sanchez-Cuellar; M de Pedro; R Martin-Granizo; A Berguer
Journal:  J Oral Maxillofac Surg       Date:  2001-02       Impact factor: 1.895

6.  Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic.

Authors:  Dennis H Osmond; Susan Buchbinder; Amber Cheng; Alison Graves; Eric Vittinghoff; Cynthia K Cossen; Bagher Forghani; Jeffrey N Martin
Journal:  JAMA       Date:  2002-01-09       Impact factor: 56.272

7.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

8.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

9.  Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma.

Authors:  N Dupin; C Fisher; P Kellam; S Ariad; M Tulliez; N Franck; E van Marck; D Salmon; I Gorin; J P Escande; R A Weiss; K Alitalo; C Boshoff
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

10.  Human herpesvirus-8 (Kaposi's sarcoma-associated virus) ORF50 increases in vitro cell susceptibility to human immunodeficiency virus type 1 infection.

Authors:  Elisabetta Caselli; Monica Galvan; Fabio Santoni; Antonella Rotola; Arnaldo Caruso; Enzo Cassai; Dario Di Luca
Journal:  J Gen Virol       Date:  2003-05       Impact factor: 3.891

View more
  3 in total

Review 1.  Comprehensive analysis of 225 Castleman's diseases in the oral maxillofacial and neck region: a rare disease revisited.

Authors:  Xiaotong He; Qiong Wang; Yaping Wu; Jiaan Hu; Dongmiao Wang; Bin Qi; Wei Zhang; Yanling Wang; Jie Cheng
Journal:  Clin Oral Investig       Date:  2017-10-04       Impact factor: 3.573

2.  International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.

Authors:  Frits van Rhee; Eric Oksenhendler; Gordan Srkalovic; Peter Voorhees; Megan Lim; Angela Dispenzieri; Makoto Ide; Sophia Parente; Stephen Schey; Matthew Streetly; Raymond Wong; David Wu; Ivan Maillard; Joshua Brandstadter; Nikhil Munshi; Wilbur Bowne; Kojo S Elenitoba-Johnson; Alexander Fössa; Mary Jo Lechowicz; Shanmuganathan Chandrakasan; Sheila K Pierson; Amy Greenway; Sunita Nasta; Kazuyuki Yoshizaki; Razelle Kurzrock; Thomas S Uldrick; Corey Casper; Amy Chadburn; David C Fajgenbaum
Journal:  Blood Adv       Date:  2020-12-08

3.  Castleman's Disease Presenting as a Parotid Mass in the Pediatric Population: A Report of 2 Cases.

Authors:  Sean W Delaney; Shengmei Zhou; Dennis Maceri
Journal:  Case Rep Otolaryngol       Date:  2015-10-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.